Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial.
| Autor: | Ohlmann, Carsten-Henning1,2 carsten.ohlmann@uks.eu, Jäschke, Michelle1, Jaehnig, Peter3, Krege, Susane2,4, Gschwend, Jürgen2,5, Rexer, Heidrun2, Stöckle, Michael1 |
|---|---|
| Zdroj: | Trials. 10/4/2017, Vol. 18, p1-9. 9p. 1 Diagram, 1 Chart. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|